Kroger launches Kroger Rewards World Elite Mastercard
The new credit card turns everyday spending into grocery savings with no annual fee, no spending caps and points that never expire.
The new credit card turns everyday spending into grocery savings with no annual fee, no spending caps and points that never expire.
Pharmacy professionals are invited to share perspectives on reimbursement, specialty pharmacy growth, clinical services, AI adoption, and technology barriers.
SimpleScreen CRC expands screening options for adults age 45 and older, providing another way to help reach people who otherwise may remain unscreened.
Former House Majority Leader and global business executive brings decades of public policy and private-sector experience to lead the industry at a pivotal moment for American medical innovation.
A national pharmacy coalition says the CMS RFI is an important step toward implementing recently enacted PBM reforms.
New Acosta Group research identifies pathways to capture more food and beverage occasions.
Turning pharmacy inventory into a managed asset across healthcare networks.
More than 41,000 children in the state were enrolled in SNAP in 2025, according to the 2026 Rhode Island KIDS COUNT Factbook.
“Julie has been at the center of some of the most important OTC switches of the past several decades, helping shape the science that gives regulators confidence and consumers greater access to self-care products.”
The latest cuts add to over 10,000 price reductions Target made last year to offer shoppers more affordable options.
Holiday is where culture meets the cart.
AI-powered insights help commercial teams identify top-prescribing HCPs whose patients may be candidates for their devices.
Following tireless advocacy against AB 2030, association pledges continued defense of consumer access and science-based policy in face of unsupported restrictions on weight management and sports nutrition dietary supplements
"CHPA is disappointed that AB 2030, as signed into law, does not strike a better balance between our shared goal of protecting minors and preserving access to safe, beneficial products for adults who use them responsibly."
After final approval, Lupin will manufacture the product at its Somerset, New Jersey, facility.
Dry eye disease (DED) is one of the most common ocular surface disorders, affecting an estimated 6 million people in Canada and 1.6 billion globally.